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The absence of demonstrable type specific antibodies in the serum 
of rabbits immunized with Type III pneumococcus has been the com- 
mon experience of investigators working with  this  organism  (1--4). 
Yoshioka (5)  obtained type specific agglutinins in the serum of im- 
munized rabbits,  but with irregularity.  He attributed his  positive 
results to  the use of one strain of Type III,  since, with two other 
strains, no specific antibody production was elicited.  Immunization 
of sheep and horses with Type III pneumococcus has resulted in the 
development of type specific agglutinins in the sera of these animals 
(6), but the titre has been low and passive protection slight. 
This experience with Pneumococcus mucosus is but a  confirmation 
of the earlier observations (7)  that the serum of animals immunized 
with certain of the encapsulated organisms fails to show agglutinins. 
This failure to demonstrate antibodies in serum under these conditions 
has  been  usually  attributed  to  the  inagglutinability of  organisms 
possessing a  mucoid capsule or to the absence of agglutinins in the 
test  serum.  Porges  (8)  found  that  if  encapsulated  Friedl~tnder 
bacilli were first subjected to  a  process of decapsulation, they then 
became agglutinable in immune serum.  Hanes (1) reported that Type 
III pneumococci  were agglutinated in their homologous  immune serum 
following decapsulation of  the organisms by means  of  the Porges 
method. 
In  the course of a  series of investigations on  immunity to  Type 
III pneumococcus, the response of rabbits to immunization with this 
organism was investigated. 
713 714  STUDmS O~ m~ri~riTY  To I,  rrEtr~ococctrs  mrcosus  (Tla'~. IrI) 
EXPERIMENTAL. 
Antigen.--Three  different strains  of Type III pneumococcus were employed. 
These strains were derived from the blood of patients suffering from lobar pneu- 
monia  and  possessed  all  the  characteristics  of  Type  III.  They  were  Gram- 
positive diplococci; they showed capsule formation when suitably stained;  they 
grew on blood agar plates  with  the  production of large  mucoid colonies;  they 
were  bile-soluble;  they  agglutinated  promptly  in  Type  III  antipneumococcus 
horse  serum;  they  were  virulent  for mice in 0.0000001  cc. doses.  Both  living 
organisms and vaccine were used for injection.  A  16 hour plain  broth culture 
was used for the living organisms.  The vaccine was made  by  centrifuging such 
a culture, resuspending the organisms in physiological salt solution,  and  heating 
at 56  ° for half an hour. 
Methods  of Immunization.--Three  methods  of immunization  were employed. 
(1)  The  intravenous  injection  of  vaccine  according  to  the  method  described 
by  Cole  and  Moore  (9).  This  method  consists  in  alternating  for  6  weeks  a 
week of daily injections of 1 cc. of vaccine with a week of rest.  (2)  Following a 
week of intravenous vaccine injections of 1 cc. each day, living  organisms  were 
injected  at 3  to 4  day intervals in increasing amounts from 0.1  to  10 cc.  over 
a period of 4 weeks.  (3)  Living organisms were injected intravenously from the 
beginning of immunization; 1 cc. was given daily for 6 days followed by increas- 
ing doses from 3 to 10 cc. at 3 to 4 day intervals over a period of 4  weeks. 
All animals were bled 10 to 12 days after the last immunizing dose. 
Agglutinin Reaction.--0.5  cc.  of a  saline  suspension  of heat-killed  organisms 
was  added  to an equal volume of the serum dilutions.  In the tests with  type 
specific  pneumococci, a  positive reaction,  if present, usually  appeared immedi- 
ately and  the final  reading was  made after the tubes had remained 2 hours  in 
the water bath at 37°C.  When decapsulated Type III pneumococci or R  strains 
of pneumococci were used, the reading was made after the tubes  had  remained 
2 hours in the water bath  at  37°C.  and overnight in the ice box. 
Precipitin  Reaction.  Nucleoprotein.--The  nucleoprotein  solutions  of  Pnuemo- 
coccus used as precipitinogen in the tests were made by the method described by 
Avery and Morgan (10).  They  contained  approximately 3  mg.  of  N  per  cc. 
0.2  cc.  of the  test  serum diluted to 0.5 cc. by the addition of physiological salt 
solution  was  added  to  0.5  cc.  of  the  nucleoprotein  solution.  Readings  were 
made after 2 hours in the water bath at 37°C. and overnight in the ice box. 
Soluble  Specific  Substance.--This  substance,  representing  the  N-free  carbo- 
hydrate derived in a purified state from Type III pneumococci according to the 
method  described  by  Heidelberger  and  Avery  (11),  was  used  in  dilutions  of 
1-10,000,  1-20,000,  1-40,000,  and  1-100,000.  Dilutions  of  this  degree  were 
employed in order  to escape the inhibition  zone experienced  (12)  when  higher 
concentrations are tested.  0.2 cc. of serum diluted to 0.5 cc. by the addition of 
physiological salt  solution was added to 0.5 cc. of the different dilutions of the 
soluble  specific  substance.  The precipitin  reaction is usually immediate;  how- 
ever, the final reading was made after 2 hours in the water bath at 37°C. WILLIAM  S.  TILLETT  715 
Passive Protection Tests.--These tests were carried out in mice by the simulta- 
neous injection intraperitoneally  of 0.2 cc. of serum and culture dilution, accord- 
hag to the method pre~6ously described (13). 
The results obtained in the experiments to be reported involve the 
activities  of  two  antigen-antibody  systems.  In  order to  avoid con- 
fusion as to nomenclature, certain terms used throughout the body of 
the report will be defined.  It has been shown by Avery and I-Ieidel- 
berger (14), that pneumococci are capable of stimulating the produc- 
tion of two distinct antibodies, depending in a  large measure on  the 
nature of the bacterial substances used as antigens.  An intact pneu- 
mococcal cell possessing the soluble specific substance, when employed 
antigenically,  stimulates  the  production  of  antibodies  which  are 
reactive  with  the  homologous  soluble  specific  substance.  If  the 
soluble specific substance is present in the cells used in the agglutina- 
tion  test,  type  specific  agglutination occurs;  if  the  soluble  specific 
substance is present in solution, precipitation of this substance occurs. 
The  antibody,  which  is  capable  of  agglutinating  the  type  specific 
Pneumococcus and of precipitating the type specific soluble substance 
will  be  designated  as  anti-S.  The  evidence  of  all  previous  work 
indicates that the efficacy of serum in the passive protection of mice 
against pneumococcus infection depends on the presence in the serum 
of anti-S. 
The  second  antigen-antibody  system  involves  the  nucleoprotein 
fraction of the cell and the antibody response elicited by it.  Pneu- 
mococcus nucleoprotein, in contrast to the soluble specific substances, 
is without type specificity.  The degraded R  strains  of pneumococci 
also  are  without  type specificity.  Therefore  the  use,  antigenically, 
of either nucleoprotein substance or R  strains results in the production 
oi  non-type specific antibodies,  which precipitate  the  nucleoprotein 
derived from any Pneumococcus and agglutinate all R  strains.  These 
antibodies will be designated as anti-P. 
I. A gglutinins. 
Absence of A gglutinins for the Encapsulated  Type III Pneumococcus in 
the Sera of Animals Immunized with Type III Pneumococcus. 
Twenty-eight rabbits were used in these immunization experiments. 
Twenty received vaccine alone;  six received vaccine and living organ- 716 STUDIES ON IMMUNITY TO PNEUMOCOCCUS MIICOSUS (TYPE Ill) 
isms;  two  received living  organisms  alone.  Their  sera  were  then 
tested for the presence of agglutinins against the encapsulated Type 
III  pneumococcus.  Out  of  the  twenty-eight  rabbits,  the  sera  of 
twenty-four failed to show type  specific antibodies  (anti-S).  In the 
four positive sera type specific antibodies  (anti-S) were present in low 
titre and in only one was the agglutinin reaction positive in a dilution 
of 1 to 20 (Table I).  Such results are confirmatory of the experience 
of others in working with Type III and are  in  striking contrast to 
the results obtained when rabbits are immunized with Pneumococcus 
Type I  or  Type  II,  whereby  type  specific antibodies  are  readily 
demonstrable in the immune sera. 
Presence of A gglutinins for R  Strains  of Pneumococcus  in the Sera of 
Rabbits Immunized with Type HI Pneumococcus. 
In  demonstrating the  twofold  antigenicity of pneumococcus sub- 
stances, Avery and Heidelberger (14)  showed that when intact pneu- 
mococcal cells  are  used  as  antigen  the  resultant  antibodies  consist 
chiefly of type specific agglutinins (anti-S) for the homologous organ- 
ism;  when ruptured  cells  or  solutions  of  pneumococci are  used  as 
antigen the antibody response is predominantly  of the anti-P character. 
Since the sera of rabbits immunized with Type III pneumococcus fail, 
in most instances, to show anti-S antibodies, and in view of the dual 
antigenic nature of pneumococci, these immune sera were tested for 
the  presence of  anti-P  antibodies.  Anti-P  antibodies  are  reactive 
against  the  degraded  R  strains  of  Pneumococcus.  As  has  been 
brought out by Reimann (15,  16) R  strains are avirulent, non-encap- 
sulated,  and non-type specific.  They may be derived from any of 
the fixed types of Pnettrnococcus and are agglutinated by any anti-P 
serum.  Therefore, R  strains of pneumococci are adequate in testing 
for the presence of anti-P antibodies.  The results recorded in Table 
I  were obtained by testing the sera of rabbits,  immunized with Type 
III pneumococcus, for the presence of anti-P antibodies, as evidenced 
by the agglutination of an  R  strain.  The sera of twenty-seven of 
twenty-eight rabbits possessed anti-P antibodies. 
The results of this experiment indicate that rabbits immunized with 
Type III  pneumococcus--even though  this  organism  is  one of the 
fixed types--react in the majority of instances by the production, not WILLIAM  S.  TILLETT  717 
of the type specific anti-S antibody, but of the anti-P antibody.  The 
immunological response is identical with that obtained following im- 
munization with R  strains or solutions of pneumococci.  The infer- 
ence is,  then,  that  Type III pneumococci are so  altered,  following 
introduction into the animal body, that  the type specific  antigen is 
made ineffectual and the nucleoprotein is liberated to stimulate the 
production of anti-P antibodies. 
Agglutination  of Decapsulated Pneumococd in  the  Sera  of  Rabbits 
Immunized with:  (1) Type III Pneumococcus, (2) R Strains of 
Pneumococcus, (3) Nucleoprotein  Derived  from Pneumococcus. 
Hanes (1), as previously stated, showed that Type III pneumococci, 
deprived of their capsule by means of the Porges  (8)  method, were 
agglutinated in the sera of rabbits immunized with Type In pneumo- 
cocci; whereas, when the encapsulated organisms were tested in the 
same  immune  sera,  no  agglutination  occurred.  Both  Porges  and 
I-lanes infer that  the inagglutinability of encapsulated organisms is 
due, not to the absence of agglutinins in the test serum, but to the 
presence of the capsule around the organism.  As proof of this they 
show that removal of the capsule is followed by agglutination. 
Since it has been shown in Table I  that rabbits  immunized with 
Type III pneurnococcus possess  anti-P antibodies and, since the chief 
characteristic of anti-P antibodies is the agglutination of non-encapsu- 
lated pneumococci, an explanation of the results of Hanes is made 
possible.  R  strains  of pneumococci agglutinated by  Type III im- 
mune rabbit serum (Table I) are organisms which have been deprived 
of their capsule by cultural methods.  The Type III organisms which 
Hanes found agglutinable were deprived of their capsule by a chemical 
procedure.  The  agglutination  of  both  of  these  non-encxpsulated 
organisms is identical (.Table I)  in Type III immune rabbit serum. 
Their immunological identity is further brought out  by testing  the 
agglutination  of  chemically decapsulated  organisms  in  the  sera  of 
rabbits  immunized with  R  strains  and  with pneumococcus nucleo- 
protein.  The results (Table II) show that any anti-P serum is capable 
of agglutinating the chemically decapsulated Type III pneumococcus 
and R strains equally well.  In reports on Friedl~nder bacilli Julianelle 
(17)  obtained  similar  results;  namely,  that  decapsulated  and  R 718  STUDIES  ON IMMUNITY  TO PNEUMOCOCCUS  MUCOSUS (TYPE III) 
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strains  of  Friedliinder  bacilli  were  identical  in  their  agglutination 
reactivity in anti-P (Friedliinder) serum. 
II.  Precipitins. 
It was shown by Reimann (16) that sera which contained agglutinins 
(anti-P) for R  strains of Pneumococcus also contained precipitins for 
pneumococcus nucleoprotein solutions.  Therefore, since the sera of 
the rabbits immunized with Type III pneumococcus  possessed anti-P 
agglutinins, they were tested for the presence of precipitins for pneu- 
mococcus nucleoprotein (Table III). 
A comparison of Table III with Table I will show that all the sera 
which contained anti-P agglutinins also possessed anti-P precipitins. 
Since the nucleoprotein in this test was obtained from a  Group IV 
pneumococcus, the possibility of a  type specific reaction is excluded 
and  the  experiment further  identifies the  antibody present  in  the 
Type III immune sera as of an antiprotein character. 
The sera of the rabbits immunized to 'Type III were also tested for 
the presence of precipitins against Type III specific soluble substance 
(Table III).  As has been shown by Avery and Heidelberger  (14), 
the type specificity of pneumococci depends upon the presence of this 
substance.  They have obtained it in a highly purified state from each 
of the three fixed types of Pneumococcus.  Immune sera which pos- 
sess  type  specific  agglutinins  .(anti-S)  for  pneumococci of  a  fixed 
type also possess precipitins for the soluble specific substance derived 
from that type.  The results obtained with Type III immune rabbit 
sera used in these experiments show the concomitant occurrence of 
Type III specific agglutinins (anti-S) and precipitins for the Type III 
soluble specific substance.  On the other hand, those sera which failed 
to show type specific agglutinins (anti-S) also failed to precipitate the 
soluble specific substance.  This is further evidence that the lack of 
agglutination of the encapsulated Type III cell in homologous im- 
mune rabbit serum is due to the actual absence of the anti-S antibody 
in demonstrable quantity since such factors as were supposed to ren- 
der the  encapsulated organism inagglutinable are not present in the 
precipitin test. 722  STUDIES oN TM~UmTY  TO Pm~UMOCOCCUS  mycosus (TYPE III) 
TABLE  III. 
Precipitation of the Soluble Specific Substance of Type IH Pneuraococcus and of a 
Solution  of Pneumococcus Nucleoprotein in the Sera  of Rabbits 
Immunized with Type III Pneumococcus. 
Precipltins for 
Pzecipitins for soluble specific substance of Type III pneumococcus  solution of pneu- 
mOCOCCUS  nucleo- 
protein 
Dilutions of soluble specific substance  Dilution of 
protein 
Rabbit No. 
1-10,000  1-20,000  1-40,000  1-100,000  1-300 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
m 
m 
m 
m 
XXXX 
XXXX 
XXX 
XXXX 
I 
•  m 
i 
m 
B 
I 
XX 
X 
X 
X 
m 
m 
N 
m 
X 
X 
X 
X 
+++ 
++ 
++ 
++ 
+++ 
++ 
++ 
+++ 
++ 
++ 
++ 
++ 
++ 
++ 
+ 
++ 
++ 
++ 
+ 
++ 
++ 
+++ 
++ 
++ 
++ 
+++ 
Controls: 0.5  cc.  of various dilutions of soluble specific  substance  q-  0.5  cc. 
salt  solution:  clear.  0.5  cc.  of  various dilutions of  soluble specific  substance 
+0.2  cc. of  normal rabbit serum  -b  0.3  cc. of salt solution:  clear.  0.5  cc. of 
pneumococcus nucleoproteln solution +  0.5 cc.  of salt solution:  slightly hazy WILLIAM  S.  TILLETT  723 
III.  Passive Protection in Mice. 
The  sera  of  the  twenty=four rabbits  immunized  with  Type  III 
pneumococcus were  tested for their ability to protect mice against 
infection with Type III pneumococcus.  The dependence of passive 
protection on the presence of type specific antibodies (anti-S)  in the 
test  serum  is  well known  to  investigators working in  experimental 
pneumococcus immunity.  Therefore, it is to be expected that those 
sera containing anti-S afford some protection and that those without 
it fail.  The results recorded in Table IV show that protection parallels 
the presence of anti-S and not anti-P.  Of the twenty-four sera tested, 
the four possessing anti-S showed protection; of the twenty possessing 
no demonstrable anti-S, seventeen afforded no protection, and three 
afforded very slight protection.  The explanation of the results ob- 
tained with the latter three sera probably rests on the fact that fllese 
sera  contained sufficient type  specific  antibodies  (anti-S)  to  afford 
some protection but not  sufficient to  be demonstrable by test-tube 
agglutination.  That the mouse protection test is a more delicate test 
for the presence of anti-S than test-tube agglutination may be brought 
out by the use of Type I antipneumococcus serum.  This serum may 
be diluted to a point where no test-tube agglutination is demonstrable 
and yet such a dilution of serum affords some protection.  A further 
report will be made later on the results obtained in passive protection 
following the  use of the  sera  of rabbits  immunized with Type III 
pneumococci. 
An analysis of the antibodies present  in the sera of twenty-eight 
0.5 cc. of pneumococcus  nucleoprotein solution +  0.2 cc. of normal rabbit serum 
+  0.3 cc. of salt solution: slightly hazy. 
X × X × indicates  characteristic compact disc of type specific  precipitin reaction 
with clear supernatant fluid.  X X X indicates  compact disc with faintly cloudy 
supernatant  fluid.  X X  indicates smaller disc at bottom of tube  with  cloudy 
supernatant  fluid.  X indicates cloudy fluid.  X indicates very faintly cloudy 
fluid.  -  indicates negative. 
+ + +  indicates precipitate at bottom of tube with faintly cloudy supernatant 
fluid.  + +  indicates slight precipitate with cloudy  supernatant fluid.  +  indi- 
cates cloudy fluid.  4- indicates very faintly cloudy fluid.  -  indicates negative. 724 STUDIES ON IMMUNITY TO PNEUMOCOCCUS M-UCOSUS (TYPE in) 
rabbits immunized with Type III pneumococcus may be summarized 
as follows: 
Agglutinins.--Twenty-four  failed to show type specific agglutinins 
(anti-S).  Four possessed  type  specific  agglutinins  (anti-S)  in  low 
titre.  Twenty-seven possessed anti-P agglutinins in appreciable titre. 
One failed to show evidence of any antibody response. 
TABLE  IV. 
Summary of Passive Protection in Mice by the  Use of Sera of Rabbits  Immunized 
with Type III Pneumococcus. 
Sera of 
17 
rabbits 
Sere of 
3 
rabbits 
Sera of 
4 
rabbits 
Demonstrable anti-S 
antibodies 
Agglutinins  Preeipitins 
Absent  Absent 
Absent  Absent 
Present  Present 
Demonstrable anti-P 
antibodies 
Agglutinins  Precipitins 
Present  Present 
Present  Present 
Present  Present 
Rabbit 
No. 
6 
11 
12 
15 
16 
17 
27 
Passive protection  in mice 
against Type III pneumo- 
coccus  infection. 
Dose of culture 
D.  D.  D.  D. 
D.  D.  D.  S. 
D.  D.  D.  S. 
D.  D.  S.  S. 
S.  S.  S.  S. 
S.  S.  S.  S. 
D.  S.  S.  S. 
D.  S.  S.  S. 
D. indicates death of animal. 
S. indicates survival of animal. 
Precipitins.TThe  presence  of  precipitins  for  Type  III  soluble 
specific substance paralleled the presence of  type specific agglutinins. 
The presence of precipitins for pneumococcus nucleoprotein paralleled 
the presence of anti-P agglutinins. 
Passive Protection in  Mice.--Four  sera  possessing  demonstrable 
anti-S antibodies afforded some protection against Type III infection. 
Of  twenty sera without demonstrable anti-S,  seventeen failed  to 
confer any protection; three afforded minimal protection. WILLIAM  S.  TILLETT  725 
DISCUSSION. 
The common experience that Type III pneumococci, antigenically 
employed, fail to stimulate the production of type specific agglutinins 
(anti-S) has been encountered in a great majority (85.8 per cent) of 
the rabbits used in the experiments here reported.  It is a  striking 
fact  that  such  a  cell, possessing  a  large amount  of soluble specific 
substance, and highly virulent for mice, acts so feebly in stimulating 
type specific antibodies (anti-S); whereas Type I  and Type II pneu- 
mococci, possessing the same qualities, are so effective in producing 
homologous  type  specific  antibodies.  However,  the  presence  of 
agglutinins  for  R  pneumococci  and  precipitins  for  pneumococcus 
nucleoprotein (anti-P antibodies) is evidence that Type III pneumo- 
cocci are not without an antigenic component.  The results of these 
experiments reveal the fact that the antibody response of rabbits to 
immunization with the encapsulated Type III pneumococcus is identi- 
cal with the antibody response obtained by immunization with solu- 
tions of pneumococci.  In both  instances  the production of anti-P 
antibodies has been stimulated.  Such a result could be accomplished 
only by in vi~o disruption of the pneumococcal cells.  The inference, 
then, may be drawn that normal rabbits possess a mechanism whereby 
Type III pneumococci, following intravenous injection, are disinte- 
grated in such a manner that the part of Type III antigenic complex, 
which stimulates type specific agglutinins (anti-S), is destroyed.  The 
nucleoprotein fraction of the cell, however, remains capable of stimu- 
lating anti-P antibodies. 
The  identification of  the  antibody present  in  Type  III immune 
rabbit  serum, as being anti-P, is explanatory of Hanes'  results with 
decapsulated  Type  III  pneumococci.  By  decapsulation,  Type  III 
. pneumococci are reduced to an R form, and are agglutinated by anti-P 
antibodies.  The failure of encapsulated Type III  to  agglutinate is 
due to the actual absence of anti-S antibodies. 
CONCLUSIONS. 
1.  Type III pneumococci fail in the majority of instances to stimu- 
late the production of anti-S antibodies.  (Type specific agglutinins, 
type specific precipitins, and antibodies affording type specific protec- 
tion in mice.) 726 STUDIES ON IM-M-UNITY TO PNEUMOCOCCUS  MUCOSUS  (TYPE III) 
2.  Type  III  pneumococci  are  effective  in  the  stimulation  of  the 
production  of anti-P  antibodies  (agglutinins  for R  strains  of pneumo- 
cocci  and  precipitins  for pneumococcus  nucleoprotein).  These  anti- 
bodies are ineffectual in the passive protection of mice. 
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